The effectiveness of atorvastatin for the prevention of deep vein thrombosis in cancer patients undergoing chemotherapy
Abstract Background Deep vein thrombosis (DVT) is a common complication in cancer. Although thromboprophylaxis in cancer patients is recommended by the guidelines, clinicians’ use of thromboprophylaxis remains limited due to cost, bleeding complications, and reluctance to give injectable anticoagula...
Main Authors: | Budi Setiawan, Widi Budianto, Tri Wahyu Sukarnowati, Daniel Rizky, Eko Adhi Pangarsa, Damai Santosa, Aru Wisaksono Sudoyo, Tri Indah Winarni, Ignatius Riwanto, Rahajuningsih Dharma Setiabudy, Catharina Suharti |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | Thrombosis Journal |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12959-023-00497-0 |
Similar Items
-
Preventing Thrombosis in Cancer Patients
by: Budi Setiawan, et al.
Published: (2022-12-01) -
Correlation of Inflammation and Coagulation Markers with the Incidence of Deep Vein Thrombosis in Cancer Patients with High Risk of Thrombosis
by: Setiawan B, et al.
Published: (2022-07-01) -
A comparative study on the effects of niacin plus atorvastatin with that of fenofibrate plus atorvastatin in dyslipidemia
by: Selim Ahmed, et al.
Published: (2008-04-01) -
A comparative study on the effects of niacin plus atorvastatin with that of fenofibrate plus atorvastatin in dyslipidemia
by: Salim Ahmed, et al.
Published: (2008-06-01) -
Can atorvastatin calcium cause asymptomatic hypercalcemia?
by: Suleyman Hilmi Ipekci, et al.
Published: (2014-10-01)